What is the Krebs Biochemicals & Industries Ltd share price today?

The share price of NSE:KREBSBIO-EQ on 21 Sep 2026 (as of 10:22:04 IST) is ₹58.10

What is the NSE:KREBSBIO-EQ 52 week high low price?

Over the past 52 weeks (as of 21 Sep 2026), the NSE:KREBSBIO-EQ 52 week high low range shows a high of ₹81.80 and a low of ₹38.33

What is the Krebs Biochemicals & Industries Ltd market cap?

As on 21 Sep 2026, Krebs Biochemicals & Industries Ltd market cap is ₹123.24 Cr.

What is the shareholding pattern of Krebs Biochemicals & Industries Ltd Stock?

The shareholding pattern of Krebs Biochemicals & Industries Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 72.74% Foreign Institutional Investors (FII): 0.49% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 26.77% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Krebs Biochemicals & Industries Ltd?

The Price-to-Earnings (PE) ratio of Krebs Biochemicals & Industries Ltd is 0.00, and the Price-to-Book (PB) ratio is -0.9847, as on 21 Sep 2026.

Krebs Biochemicals & Industries Share Price

56.22-1.09 (-1.90%)

-28.77% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-1.90%

1 Week

+1.02%

1 Month

+4.87%

3 Month

-14.10%

6 Month

+19.26%

YTD

-18.57%

1 Year

-28.77%

5 Year

-69.45%

10 Year

-44.95%

Max

-58.06%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

55.40

55.10

52.86

50.81

38.33

High

58.90

62.80

66.66

71.50

81.80

About

Krebs Biochemicals & Industries Limited (KBIL) is an India-based company. The Company operates in the pharma segment. The Company’s products include lavastatin, simvastatin and simvastatin ammonium salt. The Company specializes Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

CIPLANSE

LAURUSLABSNSE

AUROPHARMANSE

LUPINNSE

DRREDDYNSE

MANKINDNSE

KREBSBIONSE

LTP

1W Low

1W High

Market cap (₹)

1868.9+15.4 (0.83%)

1832.20

1891.50

4,40,398Cr

9410.5+252.5 (2.76%)

9135.50

9461.50

2,48,664Cr

4970+157.5 (3.27%)

4794.50

4986.50

1,82,738Cr

1161+53.5 (4.83%)

1100.10

1173.50

1,15,012Cr

1386.1+28.1 (2.07%)

1351.60

1405.20

1,10,794Cr

2017.5+112 (5.88%)

1894.80

2023.50

1,05,645Cr

1713.4+70.4 (4.28%)

1634

1738.90

99,828Cr

2124.5+79.5 (3.89%)

2046.30

2129

98,070Cr

1198.3+58.3 (5.11%)

1140

1211.90

97,749Cr

2437.8+191.8 (8.54%)

2242.10

2452

95,744Cr

56.25+0.6 (1.08%)

55.10

62.80

123Cr

Krebs Biochemicals & Industries Share Price

56.22-1.09 (-1.90%)

-28.77% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years5%

3 years-10%

Last year-14%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year-37%

Stock Price CAGR

10 years-

5 years-22%

3 years-4%

1 year-29%

Return on Equity

10 years-98%

5 years0%

3 years0%

Last year0%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	5%	-10%	-14%
-	-	-	-37%
-	-22%	-4%	-29%
-98%	0%	0%	0%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

CIPLA

LAURUSLABS

AUROPHARMA

LUPIN

DRREDDY

MANKIND

KREBSBIO

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,868.9	₹440398 Cr	36.41	12.07	62.82	₹11479 Cr
9,410.5	₹248664 Cr	85.01	34.04	128.41	₹2568 Cr
4,970	₹182738 Cr	83.79	16.72	97.06	₹2163 Cr
1,161	₹115012 Cr	25.48	9.42	62.53	₹5040 Cr
1,386.1	₹110794 Cr	32.87	9.77	57.87	₹3879 Cr
2,017.5	₹105645 Cr	96.62	6.8	29.25	₹889 Cr
1,713.4	₹99828 Cr	26.89	17.95	96.84	₹3505 Cr
2,124.5	₹98070 Cr	17.74	30.95	154.36	₹5333 Cr
1,198.3	₹97749 Cr	30.34	5.32	63.99	₹4196 Cr
2,437.8	₹95744 Cr	46.87	13.75	71.08	₹1913 Cr
56.25	₹123 Cr	—	-1.15	-3.56	-₹17 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018	Mar 2018	Dec 2017	Sep 2017	Jun 2017	Mar 2017	Dec 2016	Sep 2016	Jun 2016	Mar 2016	Dec 2015	Sep 2015	Jun 2015	Mar 2015	Dec 2014	Sep 2014	Jun 2014	Mar 2014	Dec 2013	Sep 2013	Jun 2013	Mar 2013	Dec 2012	Sep 2012
₹7 Cr	₹7 Cr	₹7 Cr	₹4 Cr	₹5 Cr	₹6 Cr	₹11 Cr	₹13 Cr	₹13 Cr	₹12 Cr	₹13 Cr	₹15 Cr	₹11 Cr	₹11 Cr	₹9 Cr	₹21 Cr	₹11 Cr	₹19 Cr	₹22 Cr	₹12 Cr	₹7 Cr	₹16 Cr	₹10 Cr	₹17 Cr	₹12 Cr	₹15 Cr	₹8 Cr	₹6 Cr	₹5 Cr	₹12 Cr	₹11 Cr	₹16 Cr	₹9 Cr	₹10 Cr	₹19 Cr	₹3 Cr	₹1 Cr	₹2 Cr	₹41 L	₹39 L	₹46 L	₹39 L	₹40 L	₹39 L	₹18 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹1 Cr	₹2 Cr	₹5 Cr	₹5 Cr
₹16 L	₹2 Cr	₹40,000	₹70,000	₹1 L	₹34 L	₹25 L	₹9 L	₹3 L	₹21 L	₹3 L	₹17 L	₹4 L	₹19 L	₹2 L	₹28 L	₹13 L	₹79 L	₹20 L	₹13 L	₹3 L	₹44 L	₹6 L	₹7 L	₹5 L	₹10 L	₹2 L	₹7 L	₹18 L	₹16 L	₹12 L	₹2 L	₹3 L	₹15 L	₹1 L	₹0	₹4 L	₹90,000	₹4 L	₹2 L	₹1 L	₹32 L	₹3 L	₹68 L	₹80,000	₹1 L	₹0	-₹3 Cr	₹3 Cr	₹0	₹0	₹30,000	₹9 Cr	₹5 L	₹0	₹2 L
₹7 Cr	₹9 Cr	₹7 Cr	₹4 Cr	₹5 Cr	₹6 Cr	₹12 Cr	₹13 Cr	₹13 Cr	₹12 Cr	₹13 Cr	₹15 Cr	₹11 Cr	₹12 Cr	₹9 Cr	₹21 Cr	₹11 Cr	₹20 Cr	₹22 Cr	₹12 Cr	₹7 Cr	₹16 Cr	₹10 Cr	₹17 Cr	₹12 Cr	₹15 Cr	₹8 Cr	₹7 Cr	₹5 Cr	₹12 Cr	₹11 Cr	₹16 Cr	₹9 Cr	₹10 Cr	₹19 Cr	₹3 Cr	₹1 Cr	₹2 Cr	₹44 L	₹41 L	₹47 L	₹71 L	₹43 L	₹1 Cr	₹19 L	₹1 L	₹0	-₹3 Cr	₹3 Cr	₹0	₹0	₹30,000	₹10 Cr	₹2 Cr	₹5 Cr	₹5 Cr
₹8 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹13 Cr	₹18 Cr	₹17 Cr	₹17 Cr	₹17 Cr	₹17 Cr	₹18 Cr	₹15 Cr	₹18 Cr	₹14 Cr	₹25 Cr	₹19 Cr	₹31 Cr	₹33 Cr	₹21 Cr	₹15 Cr	₹22 Cr	₹16 Cr	₹21 Cr	₹17 Cr	₹20 Cr	₹13 Cr	₹13 Cr	₹11 Cr	₹15 Cr	₹16 Cr	₹17 Cr	₹13 Cr	₹16 Cr	₹17 Cr	₹7 Cr	₹6 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹6 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹1 Cr	-₹3 Cr	₹67 L	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹5 Cr	₹11 Cr	₹8 Cr
₹98 L	₹1 Cr	₹30 L	-₹3 Cr	-₹2 Cr	-₹5 Cr	-₹4 Cr	-₹3 Cr	-₹2 Cr	-₹3 Cr	-₹2 Cr	-₹73 L	-₹3 Cr	-₹4 Cr	-₹3 Cr	-₹2 Cr	-₹6 Cr	-₹9 Cr	-₹10 Cr	-₹8 Cr	-₹6 Cr	-₹4 Cr	-₹6 Cr	-₹3 Cr	-₹4 Cr	-₹4 Cr	-₹4 Cr	-₹5 Cr	-₹5 Cr	-₹2 Cr	-₹4 Cr	-₹54 L	-₹3 Cr	-₹5 Cr	₹4 Cr	-₹3 Cr	-₹4 Cr	-₹75 L	-₹3 Cr	-₹2 Cr	-₹2 Cr	-₹4 Cr	-₹2 Cr	-₹2 Cr	-₹3 Cr	-₹3 Cr	-₹1 Cr	-₹43 L	₹3 Cr	-₹2 Cr	-₹2 Cr	-₹2 Cr	₹8 Cr	-₹3 Cr	-₹3 Cr	-₹7 L
₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹90 L	₹74 L	₹30 L	₹28 L	₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹99 L	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹87 L	₹70 L	₹51 L	₹49 L	₹21 L	₹4 L	₹20,000	₹4 Cr	₹30,000	₹10,000	₹70,000	₹0	₹20,000	₹7 L	₹0	₹2 Cr	₹2 Cr	₹2 Cr
-₹2 Cr	-₹2 Cr	-₹3 Cr	-₹6 Cr	-₹5 Cr	-₹8 Cr	-₹8 Cr	-₹6 Cr	-₹5 Cr	-₹6 Cr	-₹5 Cr	-₹4 Cr	-₹5 Cr	-₹7 Cr	-₹6 Cr	-₹4 Cr	-₹8 Cr	-₹11 Cr	-₹13 Cr	-₹11 Cr	-₹9 Cr	-₹7 Cr	-₹8 Cr	-₹6 Cr	-₹7 Cr	-₹6 Cr	-₹7 Cr	-₹8 Cr	-₹8 Cr	-₹5 Cr	-₹6 Cr	-₹3 Cr	-₹5 Cr	-₹7 Cr	₹44 L	-₹5 Cr	-₹6 Cr	-₹4 Cr	-₹5 Cr	-₹4 Cr	-₹4 Cr	-₹6 Cr	-₹3 Cr	-₹4 Cr	-₹3 Cr	-₹6 Cr	-₹1 Cr	-₹27 L	₹3 Cr	-₹2 Cr	-₹2 Cr	-₹2 Cr	₹7 Cr	-₹6 Cr	-₹8 Cr	-₹5 Cr
-₹2 Cr	-₹2 Cr	-₹3 Cr	-₹6 Cr	-₹5 Cr	-₹8 Cr	-₹8 Cr	-₹6 Cr	-₹5 Cr	-₹6 Cr	-₹5 Cr	-₹4 Cr	-₹5 Cr	-₹7 Cr	-₹6 Cr	-₹4 Cr	-₹8 Cr	-₹11 Cr	-₹13 Cr	-₹11 Cr	-₹9 Cr	-₹7 Cr	-₹8 Cr	-₹6 Cr	-₹7 Cr	-₹6 Cr	-₹7 Cr	-₹8 Cr	-₹8 Cr	-₹5 Cr	-₹6 Cr	-₹3 Cr	-₹5 Cr	-₹7 Cr	₹44 L	-₹5 Cr	-₹6 Cr	-₹4 Cr	-₹5 Cr	-₹4 Cr	-₹4 Cr	-₹6 Cr	-₹3 Cr	-₹4 Cr	-₹3 Cr	-₹6 Cr	-₹1 Cr	-₹67 L	₹3 Cr	-₹2 Cr	-₹2 Cr	-₹2 Cr	₹7 Cr	-₹6 Cr	-₹8 Cr	-₹5 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Trade Payables

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Miscellaneous Expenses not written off

Total Assets

Book Value

Adjusted Book Value

Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Sep 2014	Jun 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹22 Cr	₹22 Cr	₹22 Cr	₹22 Cr	₹20 Cr	₹18 Cr	₹17 Cr	₹14 Cr	₹14 Cr	₹13 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹7 Cr	₹7 Cr
₹0	₹0	₹0	₹0	₹4 Cr	₹8 Cr	₹0	₹0	₹0	₹4 Cr	₹23 Cr	₹0	₹0	₹0	₹1 Cr	₹0	₹0	₹12 Cr	₹2 Cr
-₹168 Cr	-₹141 Cr	-₹121 Cr	-₹97 Cr	-₹67 Cr	-₹51 Cr	-₹31 Cr	-₹32 Cr	-₹12 Cr	-₹4 Cr	-₹14 Cr	-₹6 Cr	-₹2 Cr	₹14 Cr	₹30 Cr	₹37 Cr	₹43 Cr	₹72 Cr	₹83 Cr
-₹168 Cr	-₹141 Cr	-₹121 Cr	-₹97 Cr	-₹67 Cr	-₹51 Cr	-₹31 Cr	-₹32 Cr	-₹12 Cr	-₹4 Cr	-₹14 Cr	-₹6 Cr	-₹2 Cr	₹14 Cr	₹30 Cr	₹37 Cr	₹43 Cr	₹72 Cr	₹83 Cr
-₹146 Cr	-₹119 Cr	-₹99 Cr	-₹75 Cr	-₹43 Cr	-₹25 Cr	-₹14 Cr	-₹18 Cr	₹1 Cr	₹13 Cr	₹18 Cr	₹4 Cr	₹8 Cr	₹23 Cr	₹41 Cr	₹46 Cr	₹52 Cr	₹91 Cr	₹91 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹2 Cr	₹5 Cr	₹21 Cr	₹14 Cr	₹15 Cr	₹49 Cr	₹59 Cr	₹65 Cr	₹76 Cr	₹72 Cr	₹72 Cr	₹83 Cr
₹161 Cr	₹184 Cr	₹173 Cr	₹133 Cr	₹101 Cr	₹66 Cr	₹50 Cr	₹50 Cr	₹38 Cr	₹4 Cr	₹44 Cr	₹7 Cr	₹8 Cr	₹6 Cr	₹6 Cr	₹11 Cr	₹11 Cr	₹9 Cr	₹5 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	-₹1 Cr	-₹1 Cr	-₹2 Cr	-₹97 L	₹93 L	₹4 Cr	₹13 Cr	₹14 Cr	₹16 Cr
₹45 Cr	₹45 Cr	₹45 Cr	₹45 Cr	₹45 Cr	₹45 Cr	₹44 Cr	₹43 Cr	₹43 Cr	₹45 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹2 Cr	₹4 Cr	₹4 Cr	₹6 Cr	₹6 Cr	₹3 Cr	₹4 Cr	₹3 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹0	₹0	₹0	₹0
₹212 Cr	₹236 Cr	₹225 Cr	₹187 Cr	₹154 Cr	₹116 Cr	₹102 Cr	₹101 Cr	₹89 Cr	₹74 Cr	₹60 Cr	₹23 Cr	₹57 Cr	₹66 Cr	₹73 Cr	₹91 Cr	₹96 Cr	₹95 Cr	₹103 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹18 Cr	₹19 Cr	₹15 Cr	₹38 Cr	₹21 Cr	₹23 Cr	₹21 Cr	₹18 Cr	₹11 Cr	₹12 Cr	₹17 Cr	₹20 Cr	₹20 Cr	₹27 Cr	₹21 Cr	₹16 Cr	₹13 Cr	₹6 Cr	₹9 Cr
₹34 Cr	₹32 Cr	₹23 Cr	₹29 Cr	₹16 Cr	₹18 Cr	₹32 Cr	₹23 Cr	₹20 Cr	₹16 Cr	₹12 Cr	₹85 Cr	₹32 Cr	₹16 Cr	₹6 Cr	₹4 Cr	₹10 Cr	₹7 Cr	₹8 Cr
₹51 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹3 Cr	₹19 Cr	₹15 Cr	₹15 Cr	₹0	₹0	₹0	₹0
₹79 L	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹87 L	₹82 L	₹9 L	₹2 Cr	₹24 L	₹16 L	₹33 L	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr
₹104 Cr	₹62 Cr	₹49 Cr	₹78 Cr	₹48 Cr	₹43 Cr	₹55 Cr	₹42 Cr	₹32 Cr	₹30 Cr	₹29 Cr	₹110 Cr	₹71 Cr	₹59 Cr	₹43 Cr	₹21 Cr	₹24 Cr	₹14 Cr	₹18 Cr
₹169 Cr	₹178 Cr	₹175 Cr	₹190 Cr	₹159 Cr	₹134 Cr	₹142 Cr	₹126 Cr	₹122 Cr	₹116 Cr	₹107 Cr	₹136 Cr	₹136 Cr	₹148 Cr	₹157 Cr	₹158 Cr	₹172 Cr	₹200 Cr	₹212 Cr
₹9 Cr	₹9 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹6 Cr	₹4 Cr	₹5 Cr	₹5 Cr	₹11 L	₹7 Cr	₹3 Cr	₹3 Cr	₹5 Cr	₹7 Cr	₹2 Cr
₹212 Cr	₹194 Cr	₹183 Cr	₹143 Cr	₹111 Cr	₹66 Cr	₹53 Cr	₹56 Cr	₹48 Cr	₹31 Cr	₹61 Cr	₹93 Cr	₹93 Cr	₹86 Cr	₹86 Cr	₹87 Cr	₹83 Cr	₹81 Cr	₹87 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹314 Cr	₹312 Cr	₹303 Cr	₹288 Cr	₹261 Cr	₹243 Cr	₹234 Cr	₹230 Cr	₹227 Cr	₹213 Cr	₹167 Cr	₹164 Cr	₹164 Cr	₹164 Cr	₹162 Cr	₹155 Cr	₹167 Cr	₹161 Cr	₹159 Cr
₹168 Cr	₹163 Cr	₹156 Cr	₹149 Cr	₹143 Cr	₹138 Cr	₹133 Cr	₹129 Cr	₹124 Cr	₹120 Cr	₹116 Cr	₹114 Cr	₹114 Cr	₹105 Cr	₹96 Cr	₹86 Cr	₹80 Cr	₹70 Cr	₹60 Cr
₹146 Cr	₹150 Cr	₹147 Cr	₹139 Cr	₹118 Cr	₹105 Cr	₹101 Cr	₹101 Cr	₹102 Cr	₹93 Cr	₹51 Cr	₹51 Cr	₹51 Cr	₹58 Cr	₹66 Cr	₹69 Cr	₹87 Cr	₹90 Cr	₹99 Cr
₹1 Cr	₹16 L	₹2 Cr	₹7 Cr	₹10 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹4 Cr	₹11 Cr	₹0	₹0	₹0	₹0	₹0	₹4 Cr	₹3 Cr	₹6 Cr	₹5 Cr
₹10 Cr	₹9 Cr	₹8 Cr	₹7 Cr	₹8 Cr	₹5 Cr	₹6 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹34 Cr	₹40 Cr	₹40 Cr	₹39 Cr	₹37 Cr	₹0	₹0	₹0	₹0
₹0	₹0	₹0	₹0	₹23 L	₹21 L	₹42 L	₹41 L	₹20 L	₹20 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹159 Cr	₹161 Cr	₹159 Cr	₹154 Cr	₹138 Cr	₹115 Cr	₹111 Cr	₹109 Cr	₹109 Cr	₹107 Cr	₹92 Cr	₹98 Cr	₹97 Cr	₹105 Cr	₹109 Cr	₹72 Cr	₹91 Cr	₹96 Cr	₹105 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹6 Cr	₹10 Cr	₹12 Cr	₹26 Cr	₹17 Cr	₹15 Cr	₹9 Cr	₹12 Cr	₹5 Cr	₹6 Cr	₹5 Cr	₹31 Cr	₹31 Cr	₹30 Cr	₹29 Cr	₹29 Cr	₹21 Cr	₹48 Cr	₹47 Cr
₹5 L	₹2 Cr	₹53 L	₹88 L	₹30 L	₹20 L	₹3 Cr	₹32 L	₹2 Cr	₹3 L	₹37 L	₹62 L	₹92 L	₹8 Cr	₹13 Cr	₹28 Cr	₹30 Cr	₹26 Cr	₹30 Cr
₹14 L	₹14 L	₹9 L	₹10 L	₹71 L	₹17 L	₹17 Cr	₹42 L	₹12 L	₹27 L	₹6 Cr	₹36 L	₹33 L	₹43 L	₹37 L	₹51 L	₹42 L	₹67 L	₹96 L
₹65 L	₹54 L	₹65 L	₹59 L	₹47 L	₹31 L	₹21 L	₹33 L	₹14 L	₹8 L	₹2 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹93 L	₹0	₹0	₹0	₹0
₹3 Cr	₹5 Cr	₹3 Cr	₹8 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹4 Cr	₹6 Cr	₹3 Cr	₹59 L	₹5 Cr	₹5 Cr	₹3 Cr	₹4 Cr	₹22 Cr	₹25 Cr	₹24 Cr	₹25 Cr
₹10 Cr	₹17 Cr	₹16 Cr	₹35 Cr	₹21 Cr	₹19 Cr	₹31 Cr	₹17 Cr	₹13 Cr	₹9 Cr	₹15 Cr	₹39 Cr	₹38 Cr	₹43 Cr	₹48 Cr	₹80 Cr	₹76 Cr	₹99 Cr	₹103 Cr
-₹93 Cr	-₹44 Cr	-₹33 Cr	-₹43 Cr	-₹27 Cr	-₹24 Cr	-₹24 Cr	-₹25 Cr	-₹19 Cr	-₹20 Cr	-₹14 Cr	-₹71 Cr	-₹32 Cr	-₹16 Cr	₹5 Cr	₹59 Cr	₹52 Cr	₹85 Cr	₹85 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr
₹169 Cr	₹178 Cr	₹175 Cr	₹190 Cr	₹159 Cr	₹134 Cr	₹142 Cr	₹126 Cr	₹122 Cr	₹116 Cr	₹107 Cr	₹136 Cr	₹136 Cr	₹148 Cr	₹157 Cr	₹158 Cr	₹172 Cr	₹200 Cr	₹212 Cr
-₹68	-₹55	-₹46	-₹35	-₹24	-₹18	-₹9	-₹13	₹1	₹7	-₹5	₹4	₹8	₹24	₹43	₹45	₹52	₹106	₹120
-₹68	-₹55	-₹46	-₹35	-₹24	-₹18	-₹9	-₹12	₹1	₹7	-₹5	₹4	₹8	₹23	₹42	₹44	₹50	₹102	₹116

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Sep 2014	Jun 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007
-₹27 Cr	-₹20 Cr	-₹25 Cr	-₹45 Cr	-₹28 Cr	-₹29 Cr	-₹20 Cr	-₹17 Cr	-₹16 Cr	-₹17 Cr	-₹11 Cr	-₹4 Cr	-₹16 Cr	-₹19 Cr	-₹10 Cr	-₹15 Cr	-₹44 Cr	-₹11 Cr	-₹9 Cr
₹12 Cr	₹12 Cr	₹10 Cr	₹11 Cr	₹12 Cr	₹9 Cr	₹10 Cr	₹6 Cr	₹11 Cr	₹3 Cr	₹9 Cr	₹22 L	₹3 Cr	₹16 Cr	₹10 Cr	₹13 Cr	₹16 Cr	₹21 Cr	₹21 Cr
₹7 Cr	₹10 Cr	-₹10 Cr	₹16 Cr	₹2 Cr	-₹16 Cr	₹14 Cr	₹9 Cr	-₹2 Cr	-₹1 Cr	-₹39 Cr	₹55 Cr	₹12 Cr	₹20 Cr	₹2 Cr	-₹7 Cr	₹33 Cr	-₹2 Cr	-₹11 Cr
-₹8 Cr	₹2 Cr	-₹25 Cr	-₹17 Cr	-₹15 Cr	-₹35 Cr	₹4 Cr	-₹1 Cr	-₹8 Cr	-₹15 Cr	-₹41 Cr	₹51 Cr	-₹81 L	₹16 Cr	₹2 Cr	-₹9 Cr	₹4 Cr	₹8 Cr	₹1 Cr
-₹8 Cr	₹2 Cr	-₹25 Cr	-₹17 Cr	-₹15 Cr	-₹35 Cr	₹4 Cr	-₹6 Cr	-₹11 Cr	-₹15 Cr	-₹45 Cr	₹49 Cr	-₹2 Cr	₹7 Cr	-₹5 Cr	-₹16 Cr	-₹4 Cr	-₹1 Cr	-₹9 Cr
-₹5 Cr	-₹8 Cr	-₹13 Cr	-₹23 Cr	-₹23 Cr	-₹10 Cr	-₹4 Cr	-₹3 Cr	-₹5 Cr	-₹4 Cr	-₹3 Cr	₹7 L	₹6 Cr	-₹1 Cr	₹4 Cr	₹12 Cr	-₹4 Cr	-₹1 Cr	₹17 Cr
₹13 Cr	₹6 Cr	₹37 Cr	₹40 Cr	₹38 Cr	₹29 Cr	₹17 Cr	₹9 Cr	₹16 Cr	₹13 Cr	₹54 Cr	-₹49 Cr	-₹4 Cr	-₹6 Cr	₹72 L	₹4 Cr	₹7 Cr	₹2 Cr	-₹8 Cr
₹42,000	₹5 L	-₹1 L	-₹61 L	₹54 L	-₹17 Cr	₹17 Cr	₹30 L	-₹15 L	-₹6 Cr	₹6 Cr	₹3 L	-₹10 L	₹7 L	-₹14 L	₹9 L	-₹25 L	-₹28 L	-₹25 L
₹14 L	₹9 L	₹10 L	₹71 L	₹17 L	₹17 Cr	₹42 L	₹12 L	₹27 L	₹6 Cr	₹36 L	₹33 L	₹43 L	₹37 L	₹51 L	₹42 L	₹67 L	₹96 L	₹1 Cr
₹14 L	₹14 L	₹9 L	₹10 L	₹71 L	₹17 L	₹17 Cr	₹42 L	₹12 L	₹27 L	₹6 Cr	₹36 L	₹33 L	₹43 L	₹37 L	₹51 L	₹42 L	₹67 L	₹96 L

Fundamental Ratios

Consolidated

Standalone

No results found

Krebs Biochemicals & Industries Share Price

56.22-1.09 (-1.90%)

-28.77% past 1 Year

Shareholding summary

Promoters

72.74%

FII

0.49%

DII

Others

26.77%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
72.74%	72.74%	72.74%	72.74%	72.74%	72.74%
0.49%	0.49%	0.49%	0.49%	0.49%	0.49%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
26.77%	26.77%	26.77%	26.77%	26.77%	26.77%

Bulk & block deals

Name

Guttikonda Rajasekhar

Nk Securities Research Private Limited

N.g.c.s. (P) Ltd.

Nk Securities Research Private Limited

N.g.c.s. (P) Ltd.

Brescon Ventures Private Limited

Rachanadevi Raju Agarwal

National Isurance Co Ltd

Anapothana Vema Trust

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
26 Nov 2024	Purchase	1.67 Cr	₹115.85	1.44 L	Bulk	0.667157	NSE
19 Jul 2024	Purchase	4.27 Cr	₹114.96	3.71 L	Bulk	1.72177	NSE
19 Jul 2024	Purchase	1.36 Cr	₹115.39	1.18 L	Bulk	0.545616	NSE
19 Jul 2024	Sell	4.28 Cr	₹115.16	3.71 L	Bulk	1.72177	NSE
19 Jul 2024	Sell	1.36 Cr	₹115.52	1.18 L	Bulk	0.545616	NSE
13 Aug 2021	Sell	3.35 Cr	₹149.07	2.25 L	Bulk	1.04357	NSE
28 Dec 2020	Sell	1.38 Cr	₹137.75	1 L	Bulk	0.463809	NSE
13 Oct 2017	Sell	82.14 L	₹90	91.27 K	Bulk	0.423318	BSE
02 Jul 2014	Sell	11.32 L	₹20.02	56.56 K	Bulk	0.262344	BSE
03 May 2013	Sell	6.81 L	₹9.50	71.73 K	Bulk	0.33269	BSE

Insider trading & SAST

Client name

Mr. Avinash Ravi

Mrs. Hemalata Ravi

Ajay Ravi

Hemalata Ravi

Avinash Ravi

Mr Avinash Ravi

Mrs Hemalata Ravi

Mr Avinash Ravi

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
24 Dec 2024	Promoter	Pledge	—	—	—	2 L	11 Aug 2015	Creation	14,30,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	2.08 L	07 Jul 2015	Release	6,85,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	2 L	20 Aug 2015	Creation	8,85,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	85 K	16 Nov 2015	Release	0	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	6.85 L	16 Nov 2015	Release	2,00,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	12.30 L	16 Nov 2015	Release	2,00,000	SAST	Reg31	—
24 Dec 2024	Promoter	Others	—	—	—	2 L	04 Nov 2019	Release	0	SAST	Reg31	—
24 Dec 2024	Promoter	Others	—	—	—	2 L	04 Nov 2019	Release	0	SAST	Reg31	—
24 Dec 2024	Promoter	Others	—	—	—	2 L	04 Nov 2019	Release	0	SAST	Reg31	—
24 Dec 2024	Promoter	Others	—	—	—	2 L	04 Nov 2019	Release	0	SAST	Reg31	—

Krebs Biochemicals & Industries Share Price

56.22-1.09 (-1.90%)

-28.77% past 1 Year

Corporate Actions

Date

Type

Details

2019-01-31

Rights

21:100;86.0 (Rights ratio;Offer price)

Company details

Registered office

Kothapalli Village Anakapalli Kasimkota Mandal Vishakhapatnam Andhra Pradesh PIN: 531031 Tel No: 040-66808040 / 9121144984 Fax No: NULL Email: [email protected] / [email protected] Internet: www.krebsbiochem.com

Registrars

Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com

Management

Rakesh Kalbate, Company Secretary & Compliance Officer

R T Ravi, Chairman

Manish Jain, Managing Director & CEO

Pabitra Bhattacharya, Non Independent & Non Executive Director

Avinash Ravi, Non Independent & Non Executive Director

PM Kathariya, Non Executive Independent Director

Dipti Shah, Non Executive Independent Director

Satya Prakash Chigurupati, Non Executive Independent Director

Sumanth Karlapudi, Non Executive Independent Director

Details

BSE 524518

NSE KREBSBIO

ISIN INE268B01013

Krebs Biochemicals & Industries Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Krebs Biochemicals & Industries Share Price

Krebs Biochemicals & Industries Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Krebs Biochemicals & Industries Share Price

Krebs Biochemicals & Industries Share Price

Oscillators

Moving averages

Krebs Biochemicals & Industries Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Krebs Biochemicals & Industries Share Price

Corporate Actions

Company details

Krebs Biochemicals & Industries Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Krebs Biochemicals & Industries Share Price

News

Krebs Biochemicals & Industries informs about newspaper publication

Krebs Biochem.&Inds reports Profit after tax of Rs -5.32 Crores, in the June 2025 quarter

Krebs Biochem.&Inds - Quaterly Results

Krebs Biochem.&Inds - Quaterly Results

Krebs Biochem.&Inds - Quaterly Results

Krebs Biochemicals & Industries submits board meeting intimation

Krebs Biochemicals & Industries informs about certificate

Krebs Biochemicals & Industries informs about trading window closure

Krebs Biochemicals & Industries informs about completion of tenure of Independent Director

Krebs Biochemicals & Industries informs about updates

Krebs Biochemicals and Industries informs about newspaper publication

Krebs Biochem.&Inds - Quaterly Results

Krebs Biochem.&Inds - Quaterly Results

Krebs Biochem.&Inds - Quaterly Results

Krebs Biochem.&Inds reports Profit after tax of Rs -7.74 Crores, in the December 2024 quarter

Krebs Biochemicals & Industries informs about completion of tenure of independent director

Krebs Biochemicals & Industries informs about closure of trading window

Krebs Biochemicals & Industries informs about closure of trading window

Krebs Biochemicals & Industries informs about newspaper publication

Krebs Biochemicals & Industries informs about press release

Krebs Biochemicals & Industries Ltd Share Price Today

Krebs Biochemicals & Industries Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator